Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism FCER1A antagonists(IgE Fc receptor, alpha-subunit antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |